Click for next page ( 244


The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 243
Appendix Committee and Staff Biographies FRANK A. SLOAN, Ph.D. (Chair) is I. Alexander McMahon Professor of Health Policy and Management, Professor of Economics, and Director, Center for Health Policy, Law & Management, and holds faculty second- arv appointments in the Sanford Institute for Public Policv and the Fuoua J l l J l 1 1 ~ TO ~ A_ 1 T T ~ ~ 1 1 1 e 1 ~ 1 ~ - ~cuool of business at L,uke university. Earlier, he served on the faculties of the University of Florida (1971-1976) and Vanderbilt University (1976- 1993) and was a research economist at the Rand Corporation (1968-1971~. Among his current interests are issues related to aging, including Medi- care; health care regulation and competition; prevention of smoking and excess alcohol use; and medical malpractice. He has been a member of IOM since 1982, serving as co-chair of the Committee on the Adequacy of Nurse Staffing (1995-1996) and as a member of the Committee on Veter- ans Administration Pharmacy Formulary Analysis (1999-2000) and the Committee to Develop a National Research Agenda on Aging (1988-1991~. Between lanuary 1990 and December 2002, he served on the IOM Council. He is a co-author of The Smoking Puzzle: Information, Risk Perceptions, and Choice (Harvard University Press, 2003~. STEPHEN BERMAN, M.D., is Professor of Pediatrics, Head of the Sec- tion of Academic General Pediatrics, and Director of Children's Outcomes Research at the University of Colorado Health Sciences Center and the Children's Hospital Denver. He is also a former President (2000-2001) of the American Academy of Pediatrics (AAP), and previously chaired the AAP Committee on Child Health Financing (1993-1995~. Dr. Berman was a member of The National Academies Committee on Acute Respiratory 243

OCR for page 243
244 FINANCING VACCINES IN THE 21ST CENTURY Infections in Third World Children (1989-1992~. He conducts clinical re- search, teaches, and has written three textbook editions on pediatric algo- rithms, titled Pediatric Decision Making. He is Health Policy Consulting Editor of Pediatrics. Dr. Berman has worked in migrant and community health centers and hospital clinics in the United States and South America and has served as an international consultant for the World Health Orga- nization in India, Egypt, and the Philippines and throughout Latin America. Currently he is a practicing pediatrician who provides primary care for children with special health care needs. DAVID M. CUTLER, Ph.D., is a professor in the department of Econom- ics at the Kennedy School of Government, Harvard University (1991- present). He is also a research associate at the National Bureau of Eco- nomic Research, specializing in aging, health care, public economics, and productivity programs. During 1993, Dr. Cutler served as senior staff economist at the Council of Economic Advisers and Director of the Na- tional Economic Council. His research examines the impact of medical care on the public sector, the value of medical innovation, and how popu- lation health is changing over time. His books include The Changing Hospi- tal Industry: Comparing Not-for-Profit and For-Profit Hospitals (University of Chicago Press, 1999) and Medical Care Productivity and Output (forthcom- ing, University of Chicago Press, 2000~. He is an editor of the Journal of Health Economics. Dr. Cutler recently served on the IOM Committee on Future Research Directions in Behavioral and Social Sciences Research at the National Institutes of Health (NIH) (1999-2001) and the Committee on the NIH Research Priority-Setting Process (1998~. ERIC K. FRANCE, M.D., M.S.P.H., is Chief of Preventive Medicine at Kaiser Permanente Colorado (KPC). He also holds assistant clinical pro- fessorships in the Department of Preventive Medicine and Biometrics and the Department of Pediatrics at the Colorado Health Sciences Center. Dr. France served as a liaison member of the Advisory Committee on Immu- nization Practices (ACIP) and Chair of the Immunization Task Force for the American Association of Health Plans from 1999 to 2002. His research interests include vaccine safety and prevention interventions. He is prin- cipal investigator for the KPC Vaccine Safety Datalink project and has focused recently on the safety of the influenza vaccine among children. WILLIAM J. HALL, M.D., is Paul Fine Professor of Medicine and Direc- tor of the Center for Healthy Aging at the University of Rochester School of Medicine and Dentistry. He is the immediate past president of the American College of Physicians-American Society of Internal Medicine (ACP-ASIM), a professional organization representing over 115,000 doc-

OCR for page 243
APPENDIX E 245 tors of internal medicine. Dr. Hall has a long-standing interest in Medi- care reform and health policy. His major research interest is in the area of successful aging. He is Director of the Center for Lifetime Wellness, which designs community-based programs in prevention and lifestyle modifica- tion for older adults. He serves on a number of national committees ad- dressing issues in geriatrics, including the National Institute for Aging, American Board of Internal Medicine, American Geriatrics Society, John Hartford Foundation, and Donald Reynolds Foundation. DAVID R. JOHNSON, M.D., M.P.H., is Deputy Director for Public Health and Chief Medical Executive of the Michigan Department of Com- munity Health (1997-present). He also holds an adjunct associate profes- sorship of epidemiology at the University of Michigan School of Public Health and associate clinical professorship in the Department of Pediat- rics and Human Development at Michigan State University. Dr. Johnson recently completed a term as a member of the ACIP. While serving on ACIP, he chaired the working group that formulated initial recommenda- tions for the use of conjugate pneumococcal vaccine. He is an executive committee member for the Association of State and Territorial Health Of- ficials and chairs that association's infectious disease policy committee. In 1993, he was awarded a Distinguished Service Award by the Michigan Association of Public Health Physicians. ALISON KEITH, Ph.D., is an independent consultant who advises non- profit organizations and businesses on a range of pharmaceutical policy issues. She was previously Director of Economic and Science Policy Analy- sis at Pfizer, Inc. In this capacity, she directed a wide range of public policy initiatives related to pharmaceutical innovation, direct-to-consumer ad- vertising, health and productivity, pharmaceutical pricing, and Medicare reform. Dr. Keith has also held positions within the Bureau of Economics of the Federal Trade Commission, conducting analyses of consumer pro- tection and antitrust issues. She co-authored the Federal Trade Com- mission's staff study on Generic Substitution and Prescription Drug Prices: Economic Effects of State Drug Product Selection Laws. She has published or reviewed papers for Managerial and Decision Economics, Health Affairs, the Journal of Industrial Economics, the Journal of Health Economics, and the Jour- nal of Law and Economics. Dr. Keith received a B.A. degree in economics magna cum laude from Carleton College and earned her doctorate in eco- nomics from the University of California at Berkeley. JUNE E. O'NEILL, Ph.D., is Wollman Professor of Economics at the Zicklin School of Business and director of the Center for the Study of Busi- ness and Government at Baruch College, City University of New York.

OCR for page 243
246 FINANCING VACCINES IN THE 21ST CENTURY During 1995-1999, she served as director of the Congressional Budget Of- fice. She previously served as director of policy research at the U.S. Com- mission on Civil Rights (1986-1987), program director and senior research associate at the Urban Institute (1979-1986), and senior economist on the President's Council of Economic Advisors (1971-1976~. Dr. O'Neill's pub- lished articles and books cover several areas, including wage differen- tials, welfare, health insurance, tax and budget policy, and social security. She earned a Ph.D. in economics from Columbia University. MARK V. PAULY, Ph.D., is Bendheim Professor and Chair of the Depart- ment of Health Care Systems at Wharton School, University of Pennsyl- vania, where he has served on the faculty since 1983. Among his recent publications are Health Benefits at Work: An Economic and Political Analysis of Health Benefits at Work (AEI Press, 1999) and Supplying Vaccine: An Eco- nomic Analysis of Critical Issues (IOS Press, 1996~. Dr. Pauly served on the IOM Committee on Choice and Managed Care: Furthering the Knowl- edge Base to Ensure Public Accountability and Information for Informed Purchasing by and on Behalf of Medicare Beneficiaries (1997-1998) and the Committee on Choice and Managed Care: Assuring Public Account- ability and Information for Informed Purchasing (1995-1997~. SARA ROSENBAUM, l.D., is Interim Chair of the Department of Health Policy and Hirsh Professor of Health Law and Policy at The George Wash- ington University Medical Center, School of Public Health and Health Services. She also directs the Hirsh Health Law and Policy Program and the Center for Health Services Research and Policy. Professor Rosenbaum has played a major role in the design of federal and state health policy across a wide range of issues. During 1993-1994, she served on the White House Domestic Policy Council and directed the drafting of the Health Security Act for President Clinton. Professor Rosenbaum is co-author of Law and the American Health Care System (Foundation Press, 1997) a widely used health law textbook. She also is a recipient of The Robert Wood Johnson Foundation Investigator's Award in Health Policy Research. Pro- fessor Rosenbaum has been recognized as one of America's 500 most in- fluential health policy makers. IRIS R. SHANNON, Ph.D., R.N., is an associate professor in Health Sys- tems Management at Rush University College of Health Sciences (1988- present), where she has also held an associate professorship in the De- partment of Community Health Nursing (1974-1997~. Her research interests are centered on public health nursing and health and social pro- grams that target the poor. She was a member of the IOM Planning Com- mittee on Community Oriented Primary Care (1982~. In 1990, she chaired

OCR for page 243
APPENDIX E 247 the Committee for the National Center for Nursing Research and Demon- stration in Community-based Rural Health Care Models for Minority Populations. Dr. Shannon served as chair of the American Public Health Association's (APHA) Public Health Nursing Section (1988) and is a former President of APHA (1989~. STAFF ROSEMARY CHALK is study director for the IOM Committee on the Evaluation of Vaccine Purchase Finance in the United States. She has served as a study director or senior program officer for over a dozen stud- ies within the Institute of Medicine and the National Research Council since 1986, including studies on the public health infrastructure for im- munization, family violence, child abuse and neglect, research ethics, and education finance. Since 2000, Ms. Chalk has also directed studies on the development of child well-being indicators for the child welfare system at Child Trends in Washington, D.C. She has previously served as a consult- ant for science and society research projects in Cambridge, MA. She was the program head of the Committee on Scientific Freedom and Responsi- bility of the American Association for the Advancement of Science from 1976-1986. Ms. Chalk has a B.A. in foreign affairs from the University of ~ - . c~nc~nnah. ROBERT GIFFIN, Ph.D., is senior program officer for the IOM Com- mittee on the Evaluation of Vaccine Purchase Finance in the United States, and is involved in the development of research initiatives in quality and accountability in health care. Before coming to the IOM, he consulted to government, associations, payers, and providers on managed care and finance issues, including the design of state-managed mental health delivery systems, evaluation tools for community health agencies, and new product development for hospitals, managed care organizations, and health care associations. Dr. Giffin teaches graduate economics and stra- tegic management at Georgetown University and the Bethesda Naval Hospital. He previously held senior positions at CIGNA Corporation and the American Association of Health Plans. Dr. Giffin received a Ph.D. in economics from Temple University and a B.A. in American history from Washington University.

OCR for page 243